Biophysical comparison of soluble amyloid-β(1-42) protofibrils, oligomers, and protofilaments.

Some of the pathological hallmarks of the Alzheimer's disease brain are senile plaques composed of insoluble amyloid-β protein (Aβ) fibrils. However, much of the recent emphasis in research has been on soluble Aβ aggregates in response to a growing body of evidence that shows that these species may be more neurotoxic than fibrils. Within this subset of soluble aggregated Aβ are protofibrils and oligomers. Although each species has been widely investigated separately, few studies have directly compared and contrasted their physical properties. In this work, we examined well-recognized preparations of Aβ(1-42) oligomers and protofibrils with multiangle (MALS) and dynamic (DLS) light scattering in line with, or following, size-exclusion chromatography (SEC). Multiple SEC-MALS analyses of protofibrils revealed molecular weight (Mw) gradients ranging from 200 to 2600 kDa. Oligomeric Aβ species are generally considered to be a smaller and more nascent than protofibrils. However, oligomer Mw values ranged from 225 to 3000 kDa, larger than that for protofibrils. Root-mean-square radius (Rg) values correlated with the Mw trends with protofibril Rg values ranging from 16 to 35 nm, while oligomers produced one population at 40-43 nm with a more disperse population from 22 to 39 nm. Hydrodynamic radius (RH) measurements by DLS and thioflavin T fluorescence measurements indicated that protofibrils and oligomers had commonalities, yet electron microscopy revealed morphological differences between the two. SEC-purified Aβ(1-42) monomer at lower concentrations was slower to nucleate but formed protofibrils (1500 kDa) or soluble protofilaments (3000 kDa) depending on the buffer type. The findings from these studies shed new light on the similarities and differences between distinct soluble aggregated Aβ species.

[1]  G. J. Raymond,et al.  The most infectious prion protein particles , 2005, Nature.

[2]  M. Findeis The role of amyloid β peptide 42 in Alzheimer's disease , 2007 .

[3]  J. Hoh,et al.  Growth of β-amyloid(1-40) protofibrils by monomer elongation and lateral association. Characterization of distinct products by light scattering and atomic force microscopy , 2002 .

[4]  N. Sreerama,et al.  Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set. , 2000, Analytical biochemistry.

[5]  D. Selkoe,et al.  Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[6]  P. Lansbury,et al.  Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein. , 1997, Chemistry & biology.

[7]  P. Lansbury,et al.  Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.

[8]  Geeta S. Paranjape,et al.  Amyloid-β(1–42) Protofibrils Formed in Modified Artificial Cerebrospinal Fluid Bind and Activate Microglia , 2012, Journal of Neuroimmune Pharmacology.

[9]  L. Gasparini,et al.  Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage , 2014, Neurobiology of Aging.

[10]  D. Selkoe,et al.  Aβ Oligomers – a decade of discovery , 2007, Journal of neurochemistry.

[11]  D. Selkoe,et al.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.

[12]  H. Levine,et al.  Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solution , 1993, Protein science : a publication of the Protein Society.

[13]  R. Hepler,et al.  Solution State Characterization of Amyloid β-Derived Diffusible Ligands , 2006 .

[14]  T. Morgan,et al.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[15]  S. Younkin,et al.  Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43). , 1995, The Journal of biological chemistry.

[16]  G. Krafft,et al.  In Vitro Characterization of Conditions for Amyloid-β Peptide Oligomerization and Fibrillogenesis* , 2003, The Journal of Biological Chemistry.

[17]  D. Holtzman,et al.  Biomarkers in translational research of Alzheimer’s Disease , 2010, Neuropharmacology.

[18]  Carl W. Cotman,et al.  Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.

[19]  J. Busciglio,et al.  Different Conformations of Amyloid β Induce Neurotoxicity by Distinct Mechanisms in Human Cortical Neurons , 2006, The Journal of Neuroscience.

[20]  Michele Vendruscolo,et al.  Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism , 2013, Proceedings of the National Academy of Sciences.

[21]  D. Selkoe,et al.  Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. , 1999, The Journal of biological chemistry.

[22]  C. Finch,et al.  Self-assembly of Aβ1-42 into globular neurotoxins , 2003 .

[23]  R. Tanzi The genetics of Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[24]  Peter T. Lansbury,et al.  Observation of metastable Aβ amyloid protofibrils by atomic force microscopy , 1997 .

[25]  Geeta S. Paranjape,et al.  Amyloid-beta(1-42) fibrillar precursors are optimal for inducing tumor necrosis factor-alpha production in the THP-1 human monocytic cell line. , 2009, Biochemistry.

[26]  P. Wyatt Light scattering and the absolute characterization of macromolecules , 1993 .

[27]  D. Selkoe,et al.  Protofibrils of amyloid β-protein inhibit specific K+ currents in neocortical cultures , 2003, Neurobiology of Disease.

[28]  S. Younkin,et al.  An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. , 1994, Science.

[29]  P. Lansbury,et al.  The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. , 1993, Biochemistry.

[30]  Asad Jan,et al.  Preparation and characterization of toxic Aβ aggregates for structural and functional studies in Alzheimer's disease research , 2010, Nature Protocols.

[31]  Peter T. Lansbury,et al.  Assembly of Aβ Amyloid Protofibrils: An in Vitro Model for a Possible Early Event in Alzheimer's Disease† , 1999 .

[32]  A. Floden,et al.  β-Amyloid Stimulates Murine Postnatal and Adult Microglia Cultures in a Unique Manner , 2006, The Journal of Neuroscience.

[33]  Jill A. White,et al.  Differential effects of oligomeric and fibrillar amyloid-β1–42 on astrocyte-mediated inflammation , 2005, Neurobiology of Disease.

[34]  D. Teplow Preparation of amyloid β-protein for structural and functional studies , 2006 .

[35]  D. Walsh,et al.  Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. , 1997, The Journal of biological chemistry.

[36]  D. Walsh,et al.  Simultaneous measurement of a range of particle sizes during Aβ1-42 fibrillogenesis quantified using fluorescence correlation spectroscopy. , 2014, Biochemical and biophysical research communications.

[37]  P. Lansbury,et al.  Abeta protofibrils possess a stable core structure resistant to hydrogen exchange. , 2003, Biochemistry.

[38]  G. Glenner,et al.  Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1984 .

[39]  J. Hahn,et al.  Granular Assembly of α-Synuclein Leading to the Accelerated Amyloid Fibril Formation with Shear Stress , 2009, PloS one.

[40]  J. Rajadas,et al.  Aβ peptide conformation determines uptake and interleukin-1α expression by primary microglial cells , 2009, Neurobiology of Aging.

[41]  Dominic M. Walsh,et al.  Protofibrillar Intermediates of Amyloid β-Protein Induce Acute Electrophysiological Changes and Progressive Neurotoxicity in Cortical Neurons , 1999, The Journal of Neuroscience.

[42]  A. Michelucci,et al.  Microglial activation depends on beta‐amyloid conformation: role of the formylpeptide receptor 2 , 2010, Journal of neurochemistry.

[43]  David C Osborn,et al.  Isolated amyloid-β(1-42) protofibrils, but not isolated fibrils, are robust stimulators of microglia. , 2012, ACS chemical neuroscience.

[44]  An improved method of preparing the amyloid β-protein for fibrillogenesis and neurotoxicity experiments , 2000 .

[45]  John Hardy,et al.  Amyloid, the presenilins and Alzheimer's disease , 1997, Trends in Neurosciences.